Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ali A. Bazarbachi"'
Autor:
Rabab M. El Eit, Ahmad N. Iskandarani, Jessica L. Saliba, Mark N. Jabbour, Rami A. Mahfouz, Nizar M.A. Bitar, Hanadi R. El Ayoubi, Ghazi S. Zaatari, Francois-Xavier Mahon, Hugues B. De Thé, Ali A. Bazarbachi, Rihab R. Nasr
Publikováno v:
International Journal of Cancer. 134:988-996
Imatinib is the standard of care in chronic meloid leukemia (CML) therapy. However, imatinib is not curative since most patients who discontinue therapy relapse indicating that leukemia initiating cells (LIC) are resistant. Interferon alpha (IFN) ind
Autor:
Printz C
Publikováno v:
Cancer [Cancer] 2018 Feb 15; Vol. 124 (4), pp. 661-662.
Autor:
El Eit, Rabab M., Iskandarani, Ahmad N., Saliba, Jessica L., Jabbour, Mark N., Mahfouz, Rami A., Bitar, Nizar M.A., Ayoubi, Hanadi R. El, Zaatari, Ghazi S., Mahon, Francois‐Xavier, De Thé, Hugues B., Bazarbachi, Ali A., Nasr, Rihab R.
Publikováno v:
International Journal of Cancer; Feb2014, Vol. 134 Issue 4, p988-996, 9p